Kestra Medical Techs Sees FY2026 Sales $93.000M vs $90.946M Est

Benzinga Newsdesk www.benzinga.com Positive 83.9%

Neg 0% Neu 0% Pos 83.9%

Kestra Medical Techs (NASDAQ:KMTS) sees FY2026 sales of $93.000 million vs $90.946 million analyst estimate.

Comments

No comments yet. Be the first!